×
Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

South America Neurorehabilitation Devices Market

ID: MRFR/MED/54289-HCR
200 Pages
Rahul Gotadki
October 2025

South America Neurorehabilitation Devices Market Research Report By Type (Neuro-Robotic Devices, Wearable Devices, Non-Invasive Stimulators, Brain-Computer Interfaces), By Application (Brain Stroke, Parkinson's Disease, Multiple Sclerosis, Spinal Cord Injury, Cerebral Palsy, Schizophrenia), By End User (Rehabilitation Centers, Hospitals & Clinics, Home Care) and By Regional (Brazil, Mexico, Argentina, Rest of South America)-Forecast to 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

South America Neurorehabilitation Devices Market Infographic
Purchase Options

South America Neurorehabilitation Devices Market Summary

As per MRFR analysis, the South America neurorehabilitation devices market size was estimated at 87.32 $ Million in 2024. The South America neurorehabilitation devices market is projected to grow from 91.45 $ Million in 2025 to 145.23 $ Million by 2035, exhibiting a compound annual growth rate (CAGR) of 4.73% during the forecast period 2025 - 2035.

Key Market Trends & Highlights

The South America neurorehabilitation devices market is experiencing robust growth driven by technological advancements and increasing healthcare needs.

  • Brazil remains the largest market for neurorehabilitation devices, reflecting a strong demand for innovative solutions.
  • Mexico is emerging as the fastest-growing region, indicating a rising investment in healthcare infrastructure.
  • Technological advancements in neurorehabilitation devices are enhancing treatment outcomes and patient engagement.
  • The increasing incidence of neurological disorders and rising healthcare expenditure are key drivers propelling market growth.

Market Size & Forecast

2024 Market Size 87.32 (USD Million)
2035 Market Size 145.23 (USD Million)

Major Players

ReWalk Robotics (IL), Ekso Bionics (US), Medtronic (US), Bionik Laboratories (CA), AlterG (US), NeuroPace (US), Hocoma (CH), Kessler Foundation (US), Tyromotion (AT)

South America Neurorehabilitation Devices Market Trends

The neurorehabilitation devices market is currently experiencing notable growth, driven by an increasing prevalence of neurological disorders and a rising demand for effective rehabilitation solutions. In South America, the aging population and the incidence of conditions such as stroke and traumatic brain injuries are contributing to the expansion of this market. Furthermore, advancements in technology, including the integration of artificial intelligence and robotics, are enhancing the efficacy of rehabilitation devices. This evolution is likely to improve patient outcomes and foster greater acceptance among healthcare providers. Moreover, government initiatives aimed at improving healthcare infrastructure and increasing access to rehabilitation services are expected to further stimulate market growth. Investment in research and development is also on the rise, as stakeholders seek innovative solutions to address the unique challenges faced by patients in South America. The combination of these factors suggests a promising outlook for the neurorehabilitation devices market, as it adapts to meet the needs of a diverse patient population and leverages technological advancements to enhance rehabilitation processes.

Technological Advancements

The neurorehabilitation devices market is witnessing a surge in technological innovations, particularly in the areas of robotics and virtual reality. These advancements are enhancing the effectiveness of rehabilitation therapies, allowing for more personalized and engaging patient experiences. As technology continues to evolve, it is likely that new devices will emerge, offering improved functionalities and better integration with existing healthcare systems.

Government Support and Funding

In South America, government initiatives are increasingly focused on enhancing healthcare services, including neurorehabilitation. Funding programs and policies aimed at improving access to rehabilitation technologies are becoming more prevalent. This support is expected to drive the adoption of advanced neurorehabilitation devices, ultimately benefiting patients and healthcare providers alike.

Growing Awareness and Education

There is a rising awareness regarding the importance of neurorehabilitation among healthcare professionals and patients in South America. Educational programs and workshops are being implemented to inform stakeholders about the benefits of rehabilitation devices. This growing knowledge base is likely to lead to increased demand for neurorehabilitation solutions, as more individuals recognize their potential to improve recovery outcomes.

South America Neurorehabilitation Devices Market Drivers

Rising Healthcare Expenditure

In South America, increasing healthcare expenditure is fostering growth in the neurorehabilitation devices market. Governments and private sectors are allocating more funds towards healthcare infrastructure, which includes rehabilitation services. For instance, healthcare spending in Brazil has seen an increase of over 10% in recent years, reflecting a commitment to enhancing patient care. This financial support is crucial for the development and adoption of advanced neurorehabilitation technologies. As healthcare budgets expand, the neurorehabilitation devices market is likely to benefit from improved access to innovative devices, ultimately leading to better patient outcomes and a more robust rehabilitation ecosystem.

Technological Integration in Rehabilitation

The integration of advanced technologies such as robotics, artificial intelligence, and virtual reality into rehabilitation practices is transforming the neurorehabilitation devices market. In South America, there is a growing trend towards adopting these technologies to enhance therapeutic effectiveness. For example, robotic-assisted therapy has shown to improve motor recovery in stroke patients, which is gaining traction among rehabilitation centers. The neurorehabilitation devices market is thus experiencing a shift towards more sophisticated, technology-driven solutions that promise to deliver personalized and efficient rehabilitation experiences. This trend indicates a potential for significant growth as healthcare providers increasingly recognize the benefits of these innovations.

Aging Population and Demand for Rehabilitation

The demographic shift towards an aging population in South America is a significant driver for the neurorehabilitation devices market. As the elderly population grows, the incidence of age-related neurological conditions is likely to increase, creating a higher demand for rehabilitation services. Reports indicate that by 2030, the number of individuals aged 65 and older in South America will surpass 100 million, necessitating effective rehabilitation solutions. This demographic trend compels healthcare systems to invest in neurorehabilitation devices, ensuring that they can cater to the needs of this vulnerable population. The neurorehabilitation devices market is thus poised for growth, as it aligns with the increasing demand for specialized care for older adults.

Increasing Incidence of Neurological Disorders

The rising prevalence of neurological disorders in South America is a critical driver for the neurorehabilitation devices market. Conditions such as stroke, traumatic brain injuries, and neurodegenerative diseases are becoming more common, leading to a heightened demand for effective rehabilitation solutions. According to recent health statistics, approximately 1.5 million people in South America suffer from stroke annually, which necessitates advanced rehabilitation technologies. This growing patient population is likely to propel investments in neurorehabilitation devices, as healthcare providers seek to improve recovery outcomes. The neurorehabilitation devices market is thus positioned to expand significantly, as it addresses the urgent need for innovative therapies and devices tailored to the unique challenges posed by these disorders.

Collaboration Between Public and Private Sectors

Collaboration between public and private sectors is emerging as a vital driver for the neurorehabilitation devices market in South America. Partnerships between government agencies, healthcare providers, and private companies are fostering innovation and improving access to rehabilitation technologies. These collaborations often lead to joint ventures that focus on research and development, resulting in the creation of cutting-edge neurorehabilitation devices. For instance, initiatives in Argentina have successfully combined resources to enhance rehabilitation services, demonstrating the potential for improved patient outcomes. The neurorehabilitation devices market is likely to benefit from these synergies, as they promote the sharing of knowledge and resources, ultimately leading to a more effective rehabilitation landscape.

Market Segment Insights

By Type: Neuro-Robotic Devices (Largest) vs. Wearable Medical Devices (Fastest-Growing)

In the South America neurorehabilitation devices market, Neuro-Robotic Devices occupy the largest share, showcasing their prominence in assisting rehabilitation processes. Wearable Medical Devices are swiftly gaining traction, driven by technological enhancements and an increasing focus on personalized healthcare. Non-Invasive Stimulators and Brain-Computer Interfaces play complementary roles in the overall landscape, contributing to a diversified offering for neurorehabilitation solutions. The growth trends in this segment are significantly influenced by advancements in technology, such as improved sensor integration and artificial intelligence. The rising geriatric population, coupled with the growing incidence of neurological disorders, further supports the demand for innovative solutions. Increased investment in healthcare infrastructure across various South American countries also paves the way for wider adoption of these devices, making the market dynamic and competitive.

Neuro-Robotic Devices (Dominant) vs. Wearable Medical Devices (Emerging)

Neuro-Robotic Devices represent a dominant force in the market, recognized for their precision and effectiveness in rehabilitation therapy. These devices provide users with tailored experiences, often utilizing advanced robotics to enhance physical mobility and recovery rates. In contrast, Wearable Medical Devices are emerging as a formidable competitor, appealing to a broad demographic through accessible technology that encourages user engagement and continuous monitoring. Though currently smaller in market share, their rapid adoption reflects a shift towards more preventative care approaches that blend seamlessly with daily life, such as fitness tracking and health monitoring. Both segments highlight the importance of innovation and user-centric design in the evolving landscape of neurorehabilitation.

By Application: Brain Stroke (Largest) vs. Parkinson's Disease (Fastest-Growing)

In the Application segment of neurorehabilitation devices, Brain Stroke holds the largest market share, driven by the high incidence rate and the increasing demand for effective rehabilitation solutions. Following closely, Parkinson's Disease has emerged as the fastest-growing segment, reflecting a rising awareness of therapeutic options among patients and caregivers, along with advancements in technology that enhance treatment efficacy. Growth trends indicate a robust future for the Application segment as the population continues to age, leading to an increase in neurodegenerative conditions like Parkinson's Disease. Additionally, the push for better healthcare infrastructure and improved access to rehabilitation services is expected to further propel these segments. Innovations in device technology and increased patient engagement are facilitating a more effective recovery process, thereby expanding market opportunities.

Brain Stroke (Dominant) vs. Parkinson's Disease (Emerging)

Brain Stroke, recognized as the dominant segment due to its prevalent impact on public health, necessitates comprehensive rehabilitation strategies to aid recovery. Meanwhile, Parkinson's Disease, though currently smaller in market share, represents an emerging area with significant potential. Its growth is fueled by technological advancements in treatment devices and a deeper understanding of patient needs. The shift towards personalized therapy approaches in Parkinson's rehabilitation further enhances its appeal. As healthcare providers focus on improving patient outcomes, both segments are likely to experience transformative changes, ensuring long-term engagement and support for affected individuals.

By End-User: Rehabilitation Centers (Largest) vs. Home Care (Fastest-Growing)

In the End-User segment, Rehabilitation Centers hold the largest share, dominating the market with their extensive facilities and specialized services tailored for neurorehabilitation. Hospitals & Clinics contribute significantly to the segment, providing crucial therapies and support. However, Home Care is rapidly gaining ground, driven by increasing demand for personalized, in-home treatment options that cater to individual patient needs. The growth trends in the End-User segment are influenced by factors such as rising aging populations and higher incidences of neurological disorders. The shift towards Home Care reflects a broader trend in healthcare where patients prefer receiving treatment in the comfort of their homes. Furthermore, advancements in teletherapy technologies and remote monitoring are reshaping how care is delivered, making it more accessible and efficient.

Rehabilitation Centers (Dominant) vs. Home Care (Emerging)

Rehabilitation Centers are pivotal in providing specialized services and facilities that cater to neurorehabilitation patients, thereby establishing themselves as a dominant force in the market. Their structured programs and comprehensive rehabilitation therapies attract a larger patient base, making them essential in the recovery journey. In contrast, Home Care has emerged as a crucial segment in response to patient preferences for personalized care. The flexibility and convenience offered by Home Care services appeal to a growing demographic that seeks comfort and individualized attention. Innovations in technology also support this trend, allowing caregivers to administer effective therapies at home. The ability to combine professional care with personal comfort is attracting more patients toward the Home Care segment.

Get more detailed insights about South America Neurorehabilitation Devices Market

Regional Insights

Brazil : Strong Growth and Innovation Hub

Brazil holds a commanding 40.0% market share in the neurorehabilitation devices sector, driven by increasing incidences of neurological disorders and a growing elderly population. Government initiatives, such as the National Health System's focus on rehabilitation, and investments in healthcare infrastructure are pivotal. The demand for advanced rehabilitation technologies is rising, supported by favorable regulatory policies that encourage innovation and accessibility.

Mexico : Growing Demand for Rehabilitation Solutions

Mexico accounts for 20.0% of the South American neurorehabilitation devices market, with significant growth driven by rising healthcare expenditure and increasing awareness of rehabilitation therapies. The government is actively promoting health initiatives, which include funding for rehabilitation programs. Urbanization and improved healthcare infrastructure are also contributing to the demand for neurorehabilitation devices.

Argentina : Focus on Patient-Centric Solutions

Argentina represents 15.0% of the market share in neurorehabilitation devices, with growth fueled by a rising prevalence of stroke and other neurological conditions. The government has implemented policies to enhance healthcare access, including subsidies for rehabilitation technologies. The demand for personalized rehabilitation solutions is increasing, reflecting a shift towards patient-centered care in the healthcare system.

Rest of South America : Varied Market Dynamics Across Regions

The Rest of South America holds a 12.32% market share in neurorehabilitation devices, characterized by diverse healthcare needs and varying levels of infrastructure development. Countries like Chile and Colombia are witnessing growth due to increased investment in healthcare and rehabilitation services. Local players are emerging, while international companies are expanding their presence to tap into these markets, driven by unique regional demands.

South America Neurorehabilitation Devices Market Regional Image

Key Players and Competitive Insights

The neurorehabilitation devices market in South America is characterized by a dynamic competitive landscape, driven by technological advancements and an increasing demand for effective rehabilitation solutions. Key players such as ReWalk Robotics (IL), Ekso Bionics (US), and Medtronic (US) are at the forefront, each adopting distinct strategies to enhance their market presence. ReWalk Robotics (IL) focuses on innovation in exoskeleton technology, aiming to improve mobility for individuals with spinal cord injuries. Meanwhile, Ekso Bionics (US) emphasizes partnerships with rehabilitation centers to expand its reach and integrate its devices into clinical practices. Medtronic (US) leverages its extensive portfolio to offer comprehensive solutions, including neurostimulation devices, thereby positioning itself as a leader in the market. Collectively, these strategies contribute to a competitive environment that is increasingly centered on technological innovation and strategic collaborations.

In terms of business tactics, companies are localizing manufacturing to reduce costs and enhance supply chain efficiency. This approach is particularly relevant in South America, where logistical challenges can impact product availability. The market structure appears moderately fragmented, with several players vying for market share. However, the influence of major companies is significant, as they set industry standards and drive technological advancements that smaller firms often follow.

In October 2025, ReWalk Robotics (IL) announced a partnership with a leading rehabilitation hospital in Brazil to conduct clinical trials for its latest exoskeleton model. This strategic move is likely to enhance the company's visibility in the region and facilitate the adoption of its technology in clinical settings, potentially leading to improved patient outcomes and increased sales. The collaboration underscores the importance of clinical validation in the neurorehabilitation sector, where evidence-based practices are paramount.

In September 2025, Ekso Bionics (US) launched a new version of its EksoGT exoskeleton, featuring advanced AI capabilities for personalized rehabilitation. This innovation is expected to significantly improve user experience and outcomes, positioning the company as a pioneer in integrating AI into rehabilitation devices. The introduction of such technology may attract more healthcare providers to adopt Ekso's solutions, thereby expanding its market share in South America.

In August 2025, Medtronic (US) expanded its product line by introducing a new neurostimulation device specifically designed for stroke rehabilitation. This strategic expansion not only diversifies Medtronic's offerings but also addresses a critical need in the market, as stroke recovery remains a significant challenge in rehabilitation. By enhancing its product portfolio, Medtronic is likely to strengthen its competitive position and appeal to a broader range of healthcare providers.

As of November 2025, current trends in the neurorehabilitation devices market include a strong emphasis on digitalization, sustainability, and the integration of AI technologies. These trends are reshaping the competitive landscape, as companies increasingly seek strategic alliances to enhance their technological capabilities and market reach. The shift from price-based competition to a focus on innovation and technology is evident, with firms prioritizing the development of advanced solutions that improve patient outcomes and operational efficiency. Looking ahead, competitive differentiation will likely hinge on the ability to innovate and adapt to evolving market demands, underscoring the importance of reliable supply chains and cutting-edge technology.

Key Companies in the South America Neurorehabilitation Devices Market market include

Industry Developments

In recent months, the South America Neurorehabilitation Devices Market has witnessed significant developments, particularly in Brazil and Argentina, where increasing government initiatives aim to improve technological integration in healthcare. Companies like KinaTrax and Medtronic have shown notable advancements in their product offerings, enhancing rehabilitation outcomes for neurological patients.

Current affairs reflect a growing collaboration between private and public sectors to address the rising demand for neurorehabilitation solutions.In terms of mergers and acquisitions, AlterG completed a partnership with Hanger Orthopedic Group in February 2023 to expand its reach in Brazil, aiming to combine its strengths in rehabilitation technology.

Additionally, MindMaze announced an acquisition of a local startup focused on virtual reality applications for neurorehabilitation in March 2023. The market is experiencing substantial growth, with an estimated valuation increase, projected to reach USD 800 million by 2025, driven by advancements in technology and rising stroke rates across South America. A notable occurrence in the past few years includes Neurotech's introduction of brain-computer interface technology in August 2022, which has positively influenced rehabilitation approaches across the region.

Future Outlook

South America Neurorehabilitation Devices Market Future Outlook

The neurorehabilitation devices market is projected to grow at a 4.73% CAGR from 2024 to 2035, driven by technological advancements, increasing patient populations, and rising healthcare investments.

New opportunities lie in:

  • Development of AI-driven rehabilitation software solutions
  • Expansion of tele-rehabilitation services for remote patient monitoring
  • Partnerships with healthcare providers for integrated device solutions

By 2035, the market is expected to achieve substantial growth, reflecting evolving healthcare needs.

Market Segmentation

South America Neurorehabilitation Devices Market Type Outlook

  • Neuro-Robotic Devices
  • Wearable Medical Devices
  • Non-Invasive Stimulators
  • Brain-Computer Interfaces

South America Neurorehabilitation Devices Market End-User Outlook

  • Rehabilitation Centers
  • Hospitals & Clinics
  • Home Care

South America Neurorehabilitation Devices Market Application Outlook

  • Brain Stroke
  • Parkinson's Disease
  • Multiple Sclerosis
  • Spinal Cord Injury
  • Cerebral Palsy
  • Schizophrenia

Report Scope

MARKET SIZE 202487.32(USD Million)
MARKET SIZE 202591.45(USD Million)
MARKET SIZE 2035145.23(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR)4.73% (2024 - 2035)
REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR2024
Market Forecast Period2025 - 2035
Historical Data2019 - 2024
Market Forecast UnitsUSD Million
Key Companies Profiled["ReWalk Robotics (IL)", "Ekso Bionics (US)", "Medtronic (US)", "Bionik Laboratories (CA)", "AlterG (US)", "NeuroPace (US)", "Hocoma (CH)", "Kessler Foundation (US)", "Tyromotion (AT)"]
Segments CoveredType, Application, End-User
Key Market OpportunitiesIntegration of advanced robotics and artificial intelligence in neurorehabilitation devices market enhances patient outcomes and engagement.
Key Market DynamicsRising demand for innovative neurorehabilitation devices driven by technological advancements and evolving patient care standards.
Countries CoveredBrazil, Mexico, Argentina, Rest of South America

Leave a Comment

FAQs

What is the expected market size of the South America Neurorehabilitation Devices Market in 2024?

The South America Neurorehabilitation Devices Market is expected to be valued at 86.32 USD Million in 2024.

What is the projected market value for the South America Neurorehabilitation Devices Market by 2035?

By 2035, the market is expected to reach a value of 175.87 USD Million.

What is the compound annual growth rate (CAGR) of the South America Neurorehabilitation Devices Market from 2025 to 2035?

The market is anticipated to grow at a CAGR of 6.684% during the forecast period from 2025 to 2035.

Which type of neurorehabilitation device is projected to have the highest market value in 2024?

In 2024, Non-Invasive Stimulators are projected to have the highest market value at 30.0 USD Million.

What are the expected market values for Neuro-Robotic Devices by 2035?

Neuro-Robotic Devices are expected to be valued at 50.0 USD Million by 2035.

Which region is expected to dominate the South America Neurorehabilitation Devices Market in 2024?

Brazil is expected to dominate the market with a value of 22.0 USD Million in 2024.

What is the anticipated market size for Argentina in the South America Neurorehabilitation Devices Market by 2035?

Argentina's market size is anticipated to reach 30.0 USD Million by 2035.

Who are the key players in the South America Neurorehabilitation Devices Market?

Major players include KinaTrax, AlterG, Medtronic, MindMaze, and ReWalk Robotics among others.

What is the expected value of Wearable Devices in the South America Neurorehabilitation Devices Market in 2024?

Wearable Devices are expected to be valued at 20.0 USD Million in 2024.

What is the projected market growth rate for the Rest of South America region by 2035?

The market for the Rest of South America is projected to grow to 60.87 USD Million by 2035.

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions